While its developmental function is well established, accumulating evidence suggests that OCT4 is aberrantly re-expressed in various cancers, including PCa, where it contributes to tumor initiation, cancer stemness, therapy resistance, and disease progression. The gene discussed is POU5F1; the disease is cancer.